DNA Repair Deficiency as a Predictive Biomarker for Immunotherapy
Keywords:
DNA repair, biomarkers, immunotherapy, oncology, angiogenesis, cell cycle, chromatin remodelling, histone modification, mutational signature, copy-number variation, microsatellite instability, tumour suppressor, oncogeneAbstract
Mismatch-repair deficiency predicts immunotherapy benefit, but finer stratification is needed. We analysed DNA-repair signatures across 2,400 treated patients.
A composite DNA-repair deficiency score outperformed tumour mutational burden in predicting durable response, refining biomarker-driven patient selection.
##plugins.themes.default.displayStats.downloads##
##plugins.themes.default.displayStats.noStats##